Cinemark Shorts Retreat as Morgan Stanley Lifts Target to $45

CNK reports Q3 results on November 6, with the two most active signals ahead of the print pointing in the same direction: short sellers are reducing exposure, and the Street's most recent move was a target increase.

Short interest has dropped nearly 14% over the past week to 6.4% of the free float, unwinding a build that pushed the position above 9 million shares in mid-October. That drawdown is meaningful: at the October peak, short interest was running near its highest levels in several months. The retreat has come quickly, with daily estimates falling from roughly 9 million shares on October 19 to 7.4 million by November 2. Borrow conditions remain loose throughout, with availability at 1,380%, meaning there is roughly 14 times as much stock available to lend as there is currently short. Cost to borrow has nudged up 23% over the past week to 0.54%, though that absolute level is still negligible. Shares are down 2.6% on the week at $38.51, broadly in line with the median decline across the closest peers: MCS fell 4.3%, IMAX dropped 4.4%, and AMC bucked the group with a 10.4% gain.

The analyst picture shifted in CNK's favour on November 2, when Morgan Stanley raised its price target from $40 to $45 while keeping an Equal-Weight rating, the same analyst who had trimmed the target in September. JP Morgan made a similar move in late October, lifting its target from $39 to $41 on a Neutral rating. The consensus mean sits at $41.82, a little above the current price. The bull case centres on a stronger 2026 film slate supporting a path toward $3.4 billion in revenue and $710 million in EBITDA, with record concession revenue per head of $8.58 and a leverage ratio of 2.6x that leaves room for capital returns. The bear case is concentrated in the international segment, where attendance fell roughly 7% in the most recent quarter on a weaker local-language lineup, pushing EBITDA margins to just 10.7%. With JP Morgan having downgraded the stock in August before nudging the target back up in October, the Neutral camp's confidence appears conditional on content delivery.

The options market is offering a different read from the short book. The put/call ratio has dropped to 0.70, well below its 20-day average of 0.83 and roughly 0.75 standard deviations below the mean, suggesting call positioning is running relatively heavy ahead of the print. That is a shift from early October, when the ratio was running above 1.1 for several consecutive sessions. The ORTEX short score has also eased from 48.9 on October 20 to 45.2 on November 2, still in mid-range territory but moving in the direction of reduced short pressure. EPS momentum ranks in the 89th percentile on a 30-day basis and the 98th percentile on forward estimates year-over-year, among the stronger factor readings in the snapshot.

Orbis Investment Management, the second-largest disclosed holder at 13.1% of shares, has built its position from 9.8% over successive filings. BlackRock holds 14.6% and added 924,564 shares as of September 30. Lavaca Capital entered the top holders as a substantial new position. Wellington Management, by contrast, trimmed from 8.3% to 6.7% in its most recent 13G/A. No 13D activist is on the register. The November 6 print will test whether the domestic attendance recovery and concession strength visible in Q2 extended into Q3, and whether the international segment showed any stabilisation, the two lines the Street's cautious majority is watching most closely.